PDB Short entry for 1D4P HEADER HYDROLASE/HYDROLASE INHIBITOR 04-OCT-99 1D4P TITLE CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5- TITLE 2 AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBITOR CAVEAT 1D4P BPP B 400 HAS WRONG CHIRALITY AT ATOM C3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-THROMBIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGHT CHAIN; COMPND 5 EC: 3.4.21.5; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ALPHA-THROMBIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: HEAVY CHAIN; COMPND 11 EC: 3.4.21.5; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HIRUGEN; COMPND 15 CHAIN: H SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: BLOOD; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 13 ORGANISM_COMMON: MEDICINAL LEECH; SOURCE 14 ORGANISM_TAXID: 6421 KEYWDS THROMBIN; NONPEPTIDYL INHIBITOR; STRUCTURE-BASED DRUG DESIGN, BLOOD KEYWDS 2 CLOTTING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.Y.CHIRGADZE REVDAT 8 28-APR-21 1D4P 1 COMPND HETNAM HETSYN FORMUL REVDAT 7 29-JUL-20 1D4P 1 CAVEAT COMPND REMARK HETNAM REVDAT 7 2 1 LINK SITE REVDAT 6 13-JUL-11 1D4P 1 VERSN REVDAT 5 24-FEB-09 1D4P 1 VERSN REVDAT 4 01-APR-03 1D4P 1 JRNL REVDAT 3 26-SEP-01 1D4P 1 SHEET REVDAT 2 18-JAN-00 1D4P 1 COMPND REVDAT 1 20-OCT-99 1D4P 0 JRNL AUTH N.Y.CHIRGADZE,D.J.SALL,V.J.KLIMKOWSKI,D.K.CLAWSON, JRNL AUTH 2 S.L.BRIGGS,R.HERMANN,G.F.SMITH,D.S.GIFFORD-MOORE,J.P.WERY JRNL TITL THE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH JRNL TITL 2 LY178550, A NONPEPTIDYL, ACTIVE SITE-DIRECTED INHIBITOR. JRNL REF PROTEIN SCI. V. 6 1412 1997 JRNL REFN ISSN 0961-8368 JRNL PMID 9232642 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 98.0 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.4 REMARK 3 NUMBER OF REFLECTIONS : 19256 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.200 REMARK 3 FREE R VALUE TEST SET COUNT : 935 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.07 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1903 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2430 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2363 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 116 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.380 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.42 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1D4P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-99. REMARK 100 THE DEPOSITION ID IS D_1000009789. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-97 REMARK 200 TEMPERATURE (KELVIN) : 295 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : YALE/MSC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21650 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.070 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.25300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 150 MM SODIUM CITRATE, REMARK 280 200 MM AMMONIUM ACETATE, PH 5.6, VAPOR DIFFUSION, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.78000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.03000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.78000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.03000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 1 REMARK 465 PHE A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 GLY A 5 REMARK 465 ASP A 34 REMARK 465 GLY A 35 REMARK 465 ARG A 36 REMARK 465 TRP B 184 REMARK 465 THR B 185 REMARK 465 ALA B 186 REMARK 465 ASN B 187 REMARK 465 VAL B 188 REMARK 465 GLY B 189 REMARK 465 LYS B 190 REMARK 465 GLY B 294 REMARK 465 GLU B 295 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS B 143 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 15 -85.35 -125.36 REMARK 500 SER B 70 -179.85 -171.09 REMARK 500 TYR B 83 84.90 -155.16 REMARK 500 ASN B 89 75.70 -158.10 REMARK 500 HIS B 102 -51.04 -136.53 REMARK 500 SER B 262 -66.64 -108.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 398 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LYS B 210 O REMARK 620 2 THR B 213 O 80.7 REMARK 620 3 PHE B 251 O 96.6 95.6 REMARK 620 4 HOH B 549 O 86.4 167.0 84.6 REMARK 620 5 HOH B 553 O 165.8 86.8 91.2 106.2 REMARK 620 6 HOH B 617 O 78.4 76.6 171.3 102.1 92.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 399 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG B 269 O REMARK 620 2 LYS B 272 O 92.1 REMARK 620 3 HOH B 513 O 149.3 73.1 REMARK 620 4 HOH B 527 O 101.3 90.6 105.5 REMARK 620 5 HOH B 555 O 103.2 154.5 83.7 106.0 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D3D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 4 REMARK 900 RELATED ID: 1D3Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 2 REMARK 900 RELATED ID: 1D3T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 1 REMARK 900 RELATED ID: 1D3P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 3 DBREF 1D4P A 1 36 UNP P00734 THRB_HUMAN 328 363 DBREF 1D4P B 37 295 UNP P00734 THRB_HUMAN 364 622 DBREF 1D4P H 300 311 UNP P28501 ITHA_HIRME 54 65 SEQRES 1 A 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 A 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 A 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 H 12 GLY ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU GLN MODRES 1D4P ASN B 89 ASN GLYCOSYLATION SITE MODRES 1D4P TYS H 309 TYR O-SULFO-L-TYROSINE HET TYS H 309 16 HET NAG B 500 14 HET NA B 398 1 HET NA B 399 1 HET BPP B 400 27 HETNAM TYS O-SULFO-L-TYROSINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NA SODIUM ION HETNAM BPP 2-(4-BENZYLPIPERIDINE-1-CARBONYL)-1H-INDOLE-5- HETNAM 2 BPP CARBOXIMIDAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BPP 5-AMIDINOINDOLE-4-BENZYLPIPERIDIN FORMUL 3 TYS C9 H11 N O6 S FORMUL 4 NAG C8 H15 N O6 FORMUL 5 NA 2(NA 1+) FORMUL 7 BPP C22 H24 N4 O FORMUL 8 HOH *116(H2 O) HELIX 1 1 PHE A 15 SER A 19 5 5 HELIX 2 2 THR A 24 TYR A 32 1 9 HELIX 3 3 ALA B 77 CYS B 80 5 4 HELIX 4 4 PRO B 84 ASP B 87 5 4 HELIX 5 5 THR B 91 ASN B 93 5 3 HELIX 6 6 ASP B 158 LEU B 166 1 9 HELIX 7 7 GLU B 205 ASP B 211 1 7 HELIX 8 8 LEU B 282 PHE B 293 1 12 SHEET 1 A 7 SER B 41 ASP B 42 0 SHEET 2 A 7 GLN B 197 PRO B 202 -1 N VAL B 198 O SER B 41 SHEET 3 A 7 LYS B 171 GLY B 176 -1 N GLY B 172 O LEU B 201 SHEET 4 A 7 PRO B 244 LYS B 248 -1 O PRO B 244 N THR B 175 SHEET 5 A 7 TRP B 255 TRP B 263 -1 N TYR B 256 O MET B 247 SHEET 6 A 7 GLY B 274 HIS B 278 -1 N PHE B 275 O TRP B 263 SHEET 7 A 7 MET B 221 ALA B 224 -1 O PHE B 222 N TYR B 276 SHEET 1 B 7 GLN B 51 ARG B 56 0 SHEET 2 B 7 GLU B 61 LEU B 68 -1 O GLU B 61 N ARG B 56 SHEET 3 B 7 GLN B 51 ARG B 56 -1 N VAL B 52 O ALA B 66 SHEET 4 B 7 LEU B 95 ILE B 99 -1 N LEU B 96 O PHE B 55 SHEET 5 B 7 LYS B 113 ILE B 122 -1 O LYS B 113 N ILE B 99 SHEET 6 B 7 ALA B 137 LEU B 141 -1 O LEU B 138 N TYR B 121 SHEET 7 B 7 TRP B 73 THR B 76 -1 N VAL B 74 O MET B 139 SHEET 1 C 2 LEU B 82 TYR B 83 0 SHEET 2 C 2 LYS B 88 ASN B 89 -1 O LYS B 88 N TYR B 83 SSBOND 1 CYS A 9 CYS B 155 1555 1555 2.02 SSBOND 2 CYS B 64 CYS B 80 1555 1555 2.03 SSBOND 3 CYS B 209 CYS B 223 1555 1555 2.03 SSBOND 4 CYS B 237 CYS B 267 1555 1555 2.03 LINK ND2 ASN B 89 C1 NAG B 500 1555 1555 1.46 LINK C GLU H 308 N TYS H 309 1555 1555 1.33 LINK C TYS H 309 N LEU H 310 1555 1555 1.33 LINK O LYS B 210 NA NA B 398 1555 1555 2.56 LINK O THR B 213 NA NA B 398 1555 1555 2.42 LINK O PHE B 251 NA NA B 398 4446 1555 2.50 LINK O ARG B 269 NA NA B 399 1555 1555 2.50 LINK O LYS B 272 NA NA B 399 1555 1555 2.40 LINK NA NA B 398 O HOH B 549 1555 1555 2.63 LINK NA NA B 398 O HOH B 553 1555 1555 2.40 LINK NA NA B 398 O HOH B 617 1555 1555 2.83 LINK NA NA B 399 O HOH B 513 1555 1555 2.67 LINK NA NA B 399 O HOH B 527 1555 1555 2.39 LINK NA NA B 399 O HOH B 555 1555 1555 2.50 CISPEP 1 SER B 58 PRO B 59 0 0.41 CRYST1 71.560 72.060 73.220 90.00 101.20 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013974 0.000000 0.002767 0.00000 SCALE2 0.000000 0.013877 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013923 0.00000